Binding molecules for the treatment of myeloid cell malignancies

Details for Australian Patent Application No. 2004251890 (hide)

Owner Crucell Holland B.V.

Inventors Van Meijer, Marja; Bakker, Alexander Berthold Henrik; Van Den Oudenrijn, Sonja; Bakker, Adrianus Quirinus

Agent Davies Collison Cave

Pub. Number AU-B-2004251890

PCT Pub. Number WO2005/000894

Priority PCT/EP03/50264 25.06.03 EP; PCT/EP04/050100 09.02.04 EP

Filing date 25 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 23 September 2010

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000894 Priority application(s): WO2005/000894

23 September 2010 Application Accepted

  Published as AU-B-2004251890

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251900-Propionamide derivatives useful as androgen receptor modulators

2004251888-Asphalt-epoxy resin compositions